UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (94) 94
life sciences & biomedicine (90) 90
humans (72) 72
oncology (66) 66
female (52) 52
male (48) 48
aged (45) 45
middle aged (45) 45
adult (38) 38
cancer (26) 26
care and treatment (22) 22
patients (21) 21
aged, 80 and over (18) 18
chemotherapy (18) 18
treatment outcome (18) 18
antineoplastic agents - therapeutic use (17) 17
head and neck cancer (16) 16
squamous cell carcinoma (16) 16
analysis (15) 15
medicine & public health (15) 15
clinical trials (14) 14
metastasis (14) 14
thyroid cancer (14) 14
antineoplastic combined chemotherapy protocols - therapeutic use (13) 13
chemoradiotherapy (13) 13
pharmacology & pharmacy (13) 13
carcinoma, squamous cell - therapy (12) 12
cisplatin (12) 12
otorhinolaryngology (12) 12
research (12) 12
biological and medical sciences (11) 11
risk factors (11) 11
surgery (11) 11
antineoplastic agents - adverse effects (10) 10
cancer therapies (10) 10
drug therapy (10) 10
head and neck neoplasms - therapy (10) 10
lenvatinib (10) 10
quality of life (10) 10
tumors (10) 10
cancer patients (9) 9
cisplatin - administration & dosage (9) 9
medical sciences (9) 9
pharmacology/toxicology (9) 9
prognosis (9) 9
studies (9) 9
antineoplastic agents (8) 8
breast cancer (8) 8
cancer research (8) 8
disease-free survival (8) 8
follow-up studies (8) 8
prospective studies (8) 8
radiotherapy (8) 8
retrospective studies (8) 8
survival (8) 8
thyroid neoplasms - drug therapy (8) 8
young adult (8) 8
antimitotic agents (7) 7
antineoplastic combined chemotherapy protocols - adverse effects (7) 7
docetaxel (7) 7
dosage and administration (7) 7
drug dosages (7) 7
head and neck neoplasms - pathology (7) 7
health aspects (7) 7
medical prognosis (7) 7
medical research (7) 7
neoplasm staging (7) 7
nivolumab (7) 7
original (7) 7
phenylurea compounds - therapeutic use (7) 7
survival analysis (7) 7
survival rate (7) 7
abridged index medicus (6) 6
carcinoma, squamous cell - drug therapy (6) 6
carcinoma, squamous cell - mortality (6) 6
carcinoma, squamous cell - pathology (6) 6
cell line, tumor (6) 6
chemoradiotherapy - adverse effects (6) 6
complications and side effects (6) 6
endocrinology & metabolism (6) 6
head and neck neoplasms - drug therapy (6) 6
japan (6) 6
kaplan-meier estimate (6) 6
medical colleges (6) 6
original article (6) 6
pharmacology (6) 6
phenylurea compounds - adverse effects (6) 6
quinolines - adverse effects (6) 6
quinolines - therapeutic use (6) 6
squamous cell carcinoma of head and neck (6) 6
thyroid (6) 6
toxicity (6) 6
vascular endothelial growth factor (6) 6
cell proliferation - drug effects (5) 5
chemoradiotherapy - methods (5) 5
cisplatin - therapeutic use (5) 5
clinical trial (5) 5
drug administration schedule (5) 5
drug combinations (5) 5
fluorouracil - administration & dosage (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Annals of oncology, ISSN 0923-7534, 11/2016, Volume 27, p. vii9
Journal Article
Annals of oncology, ISSN 0923-7534, 11/2016, Volume 27, p. vii5
Journal Article
Annals of oncology, ISSN 0923-7534, 11/2016, Volume 27, p. vii25
Journal Article
Annals of oncology, ISSN 0923-7534, 11/2015, Volume 26, pp. vii53 - vii53
Journal Article
Annals of oncology, ISSN 0923-7534, 10/2014, Volume 25, p. v40
Journal Article
The New England journal of medicine, ISSN 0028-4793, 02/2015, Volume 372, Issue 7, pp. 621 - 630
Journal Article
The New England journal of medicine, ISSN 0028-4793, 11/2016, Volume 375, Issue 19, pp. 1856 - 1867
Journal Article
Journal Article
Journal Article
Cancer science, ISSN 1347-9032, 06/2019, Volume 110, Issue 6, pp. 1987 - 1994
Journal Article
Cancer, ISSN 0008-543X, 06/2018, Volume 124, Issue 11, pp. 2365 - 2372
exploratory analysis | treatment‐emergent hypertension | lenvatinib | differentiated thyroid cancer | efficacy | treatment-emergent hypertension | Life Sciences & Biomedicine | Oncology | Science & Technology | Humans | Middle Aged | Radiation Tolerance | Hypertension - drug therapy | Male | Response Evaluation Criteria in Solid Tumors | Protein Kinase Inhibitors - adverse effects | Quinolines - administration & dosage | Thyroid Neoplasms - therapy | Young Adult | Chemotherapy, Adjuvant - adverse effects | Phenylurea Compounds - adverse effects | Hypertension - chemically induced | Placebos - adverse effects | Adult | Female | Hypertension - epidemiology | Hypertension - diagnosis | Blood Pressure Determination | Placebos - administration & dosage | Thyroid Neoplasms - mortality | Double-Blind Method | Kaplan-Meier Estimate | Survival Rate | Antihypertensive Agents - therapeutic use | Protein Kinase Inhibitors - administration & dosage | Iodine Radioisotopes - administration & dosage | Phenylurea Compounds - administration & dosage | Chemotherapy, Adjuvant - methods | Thyroid Gland - pathology | Progression-Free Survival | Aged | Quinolines - adverse effects | Thyroid Neoplasms - pathology | Clinical trials | Treatment outcome | Thyroid cancer | Drug therapy | Analysis | Hypertension | Fibroblast growth factor | Iodine radioisotopes | Effectiveness | Iodine 131 | Hazards | Patients | Survival | Stem cell factor | Vascular endothelial growth factor receptors | Rank tests | Confidence intervals | Ret protein | Statistical models | Stem cells | Fibroblast growth factor receptor 4 | Fibroblast growth factor receptor 1 | Vascular endothelial growth factor | Growth factors | Fibroblast growth factor receptor 2 | Cancer | Thyroid | Fibroblast growth factor receptors | Index Medicus | Abridged Index Medicus
Journal Article